Uncovering Institutional Buying In TechnipFMC plc (NYSE: FTI)

Currently, there are 432.90M common shares owned by the public and among those 428.17M shares have been available to trade.

The company’s stock has a 5-day price change of 4.03% and 30.88% over the past three months. FTI shares are trading 30.88% year to date (YTD), with the 12-month market performance up to 94.25% higher. It has a 12-month low price of $12.64 and touched a high of $25.71 over the same period. FTI has an average intraday trading volume of 4.84 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 10.46%, 22.12%, and 32.69% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of TechnipFMC plc (NYSE: FTI) shares accounts for 99.69% of the company’s 432.90M shares outstanding.

It has a market capitalization of $11.41B and a beta (3y monthly) value of 1.67. The stock’s trailing 12-month PE ratio is 218.21, while the earnings-per-share (ttm) stands at $0.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.13% over the week and 2.82% over the month.

Analysts forecast that TechnipFMC plc (FTI) will achieve an EPS of $0.16 for the current quarter, $0.3 for the next quarter and $1.82 for 2025. The lowest estimate earnings-per-share for the quarter is $0.12 while analysts give the company a high EPS estimate of $0.22. Comparatively, EPS for the current quarter was $0 a year ago. Earnings per share for the fiscal year are expected to increase by 155.41%, and 59.27% over the next financial year.

Looking at the support for the FTI, a number of firms have released research notes about the stock. TD Cowen stated their Outperform rating for the stock in a research note on February 23, 2024, with the firm’s price target at $26-$28. Exane BNP Paribas was of a view on November 06, 2023 that the stock is Neutral, while Jefferies gave the stock Hold rating on October 13, 2023, issuing a price target of $18- $22. Kepler on their part issued Hold rating on August 01, 2023.

Most Popular

Related Posts